Trials / Completed
CompletedNCT03110393
Ambu®AuraGain™ Versus I-gel® in Obese Patients
Prospective Randomized Comparison Between a Fiber Optic Intubation Via the Ambu® AuraGain ™ or the i-Gel® Laryngeal Mask Until a Complete Airway Protection in Obese Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Schulthess Klinik · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is the randomized comparison of two laryngeal mask (Intersurgical i-gel® and Ambu®AuraGain™) in obese patients
Detailed description
Since the incidence of a difficult intubation lies between 4.5% -7.5%, the search for alternative airway devices has been forced in the past. As an option, the laryngeal mask is suitable, which has been used as a universal airway with a high degree of safety in routine anesthesia. There are numbers of different laryngeal masks available which have the characteristic to insert an endotracheal tube through the ventilation lumen. The indications for these laryngeal masks can be extended due to continuous improvements in the laryngeal masks, these laryngeal masks can also be used in obese patients. Obese patients generally have a 4-fold increased risk of a difficult airway, and a BMI over 35 is a predictor of a difficult tracheal intubation. There are no studies comparing the Intersurgical i-gel® Laryngeal Mask and the Ambu®AuraGain ™ Laryngeal Mask in obese patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ambu AuraGain | Insert and intubation of an Ambu® AuraGain™ laryngeal mask |
| DEVICE | Intersurgical i-gel | Insert and intubation of an Intersurgical i-gel® |
Timeline
- Start date
- 2017-04-20
- Primary completion
- 2017-09-06
- Completion
- 2017-09-06
- First posted
- 2017-04-12
- Last updated
- 2018-01-08
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT03110393. Inclusion in this directory is not an endorsement.